Human papillomavirus infection and loss of heterozygosity in esophageal squamous cell carcinoma

Cancer Letters

Volumn 213, Issue 2, 2004, Pages 231-239

  Si, Hua Xin ^a   Tsao, Sai Wah ^a   Poon, Cycles Suet Ping ^b   Cheung, Annie Lai Man ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NORTH DISTRICT HOSPITAL   (Hong Kong)

Author keywords

Allelic loss; Esophageal cancer; HPV; Human papillomavirus; LOH; Loss of heterozygosity

Indexed keywords

APC PROTEIN; BRCA2 PROTEIN; PROTEIN P21;

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CARCINOGENESIS; CHINA; ESOPHAGUS CARCINOMA; GEOGRAPHY; HETEROZYGOSITY LOSS; HONG KONG; HUMAN; HUMAN CELL; INFECTION RATE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; VIRUS INFECTION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRUS;

EID: 4344665576     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.04.008     Document Type: Article

References (23)

1. Ribeiro U. Jr., Posner M.C., Safatle-Ribeiro A.V., Reynolds J.C. Risk factors for squamous cell carcinoma of the oesophagus. Br. J. Surg. 83:1996;1174-1185
2. Sur M., Cooper K. The role of the human papilloma virus in esophageal cancer. Pathology. 30:1998;348-354
3. Bosch F.X., Munoz N. The viral etiology of cervical cancer. Virus Res. 89:2002;183-190
4. Syrjanen K.J. HPV infections oesophageal cancer. J. Clin. Pathol. 55:2002;721-728
5. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136
6. Dyson N., Howley P.M., Munger K., Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 243:1989;934-937
7. Chang F., Syrjanen S., Tervahauta A., Kurvinen K., Wang L., Syrjanen K. Frequent mutations of p53 gene in E with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis. Br. J. Cancer. 70:1994;346-351
8. Lam K.Y., He D., Ma L., Zhang D., Ngan H.Y., Wan T.S., Tsao S.W. Presence of human papillomavirus in esophageal squamous cell carcinomas of Hong Kong Chinese and its relationship with p53 gene mutation. Hum. Pathol. 28:1997;657-663
9. Shen Z., Cen S., Shen J., Cai W., Xu J., Teng Z., Hu Z., Zeng Y. Study of immortalization and malignant transformation of human embryonic esophageal epithelial cells induced by HPV18 E6E7. J. Cancer Res. Clin. Oncol. 126:2000;589-594
10. Sashiyama H., Shino Y., Kawamata Y., Tomita Y., Ogawa N., Shimada H., Kobayashi S., Asano T., Ochiai T., Shirasawa H. Immortalization of human esophageal keratinocytes by E6 and E7 of human papillomavirus type 16. Int. J. Oncol. 19:2001;97-103
11. Si H.X., Tsao S.W., Poon C.S., Wang L.D., Wong Y.C., Cheung A.L.M. Viral load of HPV in esophageal squamous cell carcinoma. Int. J. Cancer. 103:2003;496-500
12. Tsao S.W., Mok C.H., Oike K., Muto M., Goodman H.M., Sheets E.E., Berkowitz R.S., Knapp R.C., Lau C.C. Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors. Anticancer Res. 11:1991;1975-1982
13. Baker S.J., Fearon E.R., Nigro J.M., Hamilton S.R., Preisinger A.C., Jessup J.M., vanTuinen P., Ledbetter D.H., Barker D.F., Nakamura Y. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 244:1989;217-221
14. Ko J.M., Wong C.P., Tang C.M., Lau K.W., Lung M.L. Frequent loss of heterozygosity on multiple chromosomes in Chinese esophageal squamous cell carcinomas. Cancer Lett. 170:2001;131-138
15. Hu N., Roth M.J., Emmert-Buck M.R., Tang Z.Z., Polymeropolous M., Wang Q.H., Goldstein A.M., Han X.Y., Dawsey S.M., Ding T., Giffen C., Taylor P.R. Allelic loss in esophageal squamous cell carcinoma patients with and without family history of upper gastrointestinal tract cancer. Clin. Cancer Res. 5:1999;3476-3482
16. Hu N., Li G., Li W.J., Wang C., Goldstein A.M., Tang Z.Z., Roth M.J., Dawsey S.M., Huang J., Wang Q.H., Ding T., Giffen C., Taylor P.R., Emmert-Buck M.R. Infrequent mutation in the BRCA2 gene in esophageal squamous cell carcinoma. Clin. Cancer Res. 8:2002;1121-1126
17. Mandard A.M., Hainaut P., Hollstein M. Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat. Res. 462:2000;335-342
18. Chang F., Syrjanen S., Syrjanen K. Demonstration of human papillomavirus (HPV) type 30 in esophageal squamous-cell carcinomas by in situ hybridization. Int. J. Cancer. 55:1993;171-173
19. Togawa K., Jaskiewicz K., Takahashi H., Meltzer S.J., Rustgi A.K. Human papillomavirus DNA sequences in esophagus squamous cell carcinoma. Gastroenterology. 107:1994;128-136
20. Hasegawa M., Ohoka I., Yamazaki K., Hanami K., Sugano I., Nagao T., Asoh A., Wada N., Nagao K., Ishida Y. Expression of p21/WAF-1, status of apoptosis and p53 mutation in esophageal squamous cell carcinoma with HPV infection. Pathol. Int. 52:2002;442-450
21. Reed P.I., Johnston B.J. The changing incidence of oesophageal cancer. Endoscopy. 25:1993;606-608
22. Yang C.S. Research on esophageal cancer in China: a review. Cancer Res. 40:1980;2633-2644
23. Duensing S., Munger K. Human papillomaviruses and centrosome duplication errors: modeling the origins of genomic instability. Oncogene. 21:2002;6241-6248